HIGHLIGHTS
- who: Mahvish Faisal and colleagues from the Department of Pharmacology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu have published the research: Preclinical trials in Alzheimeru2019s disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice, in the Journal: PLOS ONE of January/13,/2023
- what: The authors provide effect sizes for each outcome, together with its power, and then use several different, freely available resources for the sample size estimates. The aim of the paper was to examine sample size and effect size of behavioural tests that are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.